Autonomix Medical Holds Annual Shareholder Meeting

• Autonomix Medical shareholders authorized a reverse stock split at the annual meeting held October 29, 2026.
• The board may implement a ratio from 1-for-2 to 1-for-25 before October 29, 2027, at its discretion.
• Shareholders approved amendments to the 2023 Stock Plan, increasing authorized issuance by 750,000 shares to 750,353 shares.
• All six board nominees were elected.
• Shareholders ratified Forvis Mazars as independent registered public accounting firm for the year ending March 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-034696), on November 03, 2026, and is solely responsible for the information contained therein.